サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1696281

血液加温器の世界市場（2025年～2033年）

Global Blood Warmer Devices Market - 2025-2033

出版日
ページ情報
英文 180 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
血液加温器の世界市場（2025年～2033年）
出版日: 2025年03月25日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の血液加温器の市場規模は、2024年に13億8,000万米ドルに達し、2033年までに121億1,000万米ドルに達すると予測され、予測期間の2025年～2033年にCAGRで24.2%の成長が見込まれます。

血液加温器は、患者に投与する前に血液や点滴の温度を上昇させ、手術や外傷治療、大量輸血の際の低体温を防ぐ医療機器です。輸液が患者の体温に合うようにし、不整脈や凝固障害などの合併症を軽減します。患者の安全性を高め、臨床転帰を改善するために、病院、救急医療サービス、軍事環境、重症治療室で広く使用されています。

市場力学

促進要因と抑制要因

低体温症の有病率の増加

世界の血液加温器市場は、外科手術、外傷症例、救急医療状況における一般的なリスクである低体温症の有病率の増加により拡大しています。医療施設では、輸液・輸血時の安全かつ効果的な体温調節を確保するため、血液加温器の採用が増加しています。低体温症に関連するリスクに対する意識の高まりと血液加温技術の進歩が市場の需要を促進しており、これらの機器は現代の医療に欠かせないものとなっています。

例えば、NCBIの2024年の調査によると、米国では低体温症に関連した死亡事故が年間700～1,500件発生しており、主に30～49歳の成人が罹患しており、男性の罹患率が10倍高いです。病院内での治療が最適化されているにもかかわらず、中等度から重度の低体温症の死亡率は50%に近づいています。

先進の血液加温器の高いコスト

特に低中所得国では、先進の血液加温器の高いコストが市場成長を妨げています。これらの機器は多額の投資を必要とし、小規模な医療施設や救急サービスでは利用しにくいです。メンテナンス、使い捨てアクセサリ、規制遵守にかかるコストは、医療提供者の経済的負担を増大させます。この入手性の障壁が、特に医療資金が不十分な地域での普及を妨げています。これを克服するためには、世界中でアクセシビリティを高め患者ケアを改善するために、価格の引き下げ、政府支援、費用対効果の高いソリューションといった戦略的活動が必要です。

例えば、血液加温器は輸血前に血液や点滴を温め、低体温を防ぎ、患者の安全性を高めるために使用される重要な医療器具です。インドでの価格はブランド、機能、技術によって異なり、250米ドルの基本的なモデルから2,000米ドルの先進のシステムまで多岐にわたります。

当レポートでは、世界の血液加温器市場について調査し、市場力学、地域とセグメントの分析、競合情勢、企業プロファイルなどを提供しています。

目次

第1章 市場のイントロダクションと範囲

第2章 エグゼクティブインサイトと重要事項

  • 市場のハイライトと戦略的ポイント
  • 主要動向と将来の予測
  • 抜粋：製品タイプ別
  • 抜粋：技術別
  • 抜粋：エンドユーザー別
  • 抜粋：地域別

第3章 市場力学

  • 影響要因
    • 促進要因
      • 低体温症の有病率の増加
      • ポータブル/バッテリー式血液加温器技術の進歩
    • 抑制要因
      • 先進の血液加温器の高いコスト
      • 厳格な規制承認とコンプライアンス要件
    • 機会
      • 正確な温度制御に向けたIoTとAIベースモニタリングシステムの統合
    • 影響の分析

第4章 戦略的考察と産業の見通し

  • マーケットリーダーとパイオニア
    • 新興パイオニアと著名企業
    • 確立されたリーダーともっとも売れているブランド
    • マーケットリーダーと確立された製品
  • CXOの視点
  • 最新の発展とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大に対し推奨される戦略
  • シナリオ分析：ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格動向
  • キーオピニオンリーダー

第5章 製品タイプ

  • ポータブル血液加温器
  • 非ポータブル血液加温器

第6章 技術別

  • 乾熱プレート加温器
  • ウォーターバス加温器
  • 赤外線加温器

第7章 エンドユーザー別

  • 病院・診療所
  • 外来手術センター
  • 救急医療サービス

第8章 地域市場の分析と成長機会

  • 北米
    • 主な地域特有の力学
      • 米国
      • カナダ
  • 欧州
    • 主な地域特有の力学
      • ドイツ
      • 英国
      • フランス
      • スペイン
      • イタリア
      • その他の欧州
  • ラテンアメリカ
    • 主な地域特有の力学
      • メキシコ
      • ブラジル
      • アルゼンチン
      • その他のラテンアメリカ
  • アジア太平洋
    • 主な地域特有の力学
      • 中国
      • インド
      • 日本
      • 韓国
      • その他のアジア太平洋
  • 中東・アフリカ
    • 主な地域特有の力学

第9章 競合情勢と市場ポジショニング

  • 競合情勢の概要と主要市場企業
  • 市場シェア分析とポジショニングマトリクス
  • 戦略的パートナーシップ、合併・買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第10章 企業プロファイル

  • 3M
  • Stryker Corporation
  • ICU Medical
  • Baxter International Inc
  • GE Healthcare
  • Belmont Medical Technologies
  • IndexIndes
  • Keewell Medical Technology Co., Ltd
  • Narang Medical Limited
  • Biegler GmbH

第11章 前提条件と調査手法

第12章 付録

目次
Product Code: MD9383

The global blood warmer devices market reached US$ 1.38 billion in 2024 and is expected to reach US$ 12.11 billion by 2033, growing at a CAGR of 24.2% during the forecast period 2025-2033.

Blood warmer devices are medical equipment that raise the temperature of blood and intravenous fluids before administration to patients, preventing hypothermia during surgeries, trauma care, or massive blood transfusions. They ensure fluids match the patient's body temperature, reducing complications like cardiac arrhythmias and coagulopathy. They are widely used in hospitals, emergency medical services, military settings, and critical care units to enhance patient safety and improve clinical outcomes.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Hypothermia

The global blood warmer devices market is growing due to the increasing prevalence of hypothermia, a common risk in surgical procedures, trauma cases, and emergency medical situations. Healthcare facilities are increasingly adopting blood warmer devices to ensure safe and effective temperature regulation during fluid and blood transfusions. The growing awareness of hypothermia-related risks and advancements in blood-warming technology are driving market demand, making these devices essential in modern medical care.

For instance, according to NCBI studies 2024, in the US, 700- 1500 hypothermia-related fatalities occur annually, primarily affecting adults aged 30-49, with men experiencing a 10 times higher incidence. Despite optimized in-hospital care, the mortality rate of moderate to severe hypothermia approaches 50%.

High Cost of Advanced Blood Warmer Devices

The high cost of advanced blood warmer devices, particularly in low- and middle-income countries, hinders market growth. These devices require substantial investment and are less accessible to smaller healthcare facilities and emergency services. The cost of maintenance, disposable accessories, and regulatory compliance adds to the financial burden on healthcare providers. This affordability barrier restricts widespread adoption, especially in regions with inadequate healthcare funding. To overcome this, strategic efforts like price reductions, government support, and cost-effective solutions are needed to enhance accessibility and improve patient care worldwide.

For instance, blood warmer devices are crucial medical tools used to heat blood and intravenous fluids before transfusions, preventing hypothermia and enhancing patient safety. Prices in India vary based on brand, features, and technology, ranging from USD 250 for basic models to USD 2,000 for advanced systems.

Segment Analysis

The global blood warmer devices market is segmented based on product type, technology, end-user and region.

Product Type:

The portable blood warmers from the product type segment are expected to dominate the blood warmer devices market with the highest market share

Portable blood warmers are lightweight medical devices used to heat blood and intravenous fluids before administration, especially in emergency and field settings. They are commonly used in ambulances, military operations, and pre-hospital care to prevent hypothermia in trauma patients. Operating on battery power or external power sources, they are ideal for remote locations and critical care transport.

The portable blood warmer market is driven by the growing demand for emergency medical services and military healthcare, particularly in cases of trauma, accidents, and battlefield injuries. Advancements in battery-operated, lightweight technologies have made them more accessible for field applications. The adoption of air and ground ambulances, stringent healthcare regulations, and expanding healthcare infrastructure in remote and rural areas are also driving market growth.

For instance, in June 2024, Danish MedTech company, MEQU, has received 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for its portable blood & IV fluid warmer system, the °M Warmer System. The FDA clearance marks a significant milestone for the company, marking the end of over a decade of product development. The company is excited to assist U.S. healthcare professionals in saving lives with the M Warmer System.

Geographical Analysis

North America is expected to hold a significant position in the blood warmer devices market with the highest market share

North America dominates the global blood warmer devices market due to its established healthcare infrastructure, rise in product launches, advanced medical technologies, and increasing surgical procedures. The rising prevalence of hypothermia in trauma and surgical patients, along with the increasing number of blood transfusions, drives demand for these devices in hospitals and emergency care settings.

For instance, in June 2023, ICU Medical, Inc., a global leader in medical device development, has introduced the Level 1 H-1200 Fast Flow Fluid Warmer, a vital tool for heating blood, blood products, and intravenous solutions in hospital settings, particularly for patients experiencing blood loss, hypothermia after surgery, or urological irrigation.

Moreover, Key market players, continuous technological advancements, and government initiatives to improve patient safety contribute to market growth. North America also benefits from military and pre-hospital emergency services that require portable, efficient blood-warming solutions.

Competitive Landscape

The major global players in the blood warmer devices market include 3M, Stryker Corporation, ICU Medical, Baxter International Inc., GE Healthcare, Belmont Medical Technologies, Indes, Keewell Medical Technology Co., Ltd, Narang Medical Limited and Biegler GmbH, among others.

Key Developments

  • In August 2024, the Delta Development Team introduced the Single Unit Blood Warmer (SUBW), a revolutionary prehospital blood delivery device that has passed rigorous FDA testing. The device is set to revolutionize blood-warming technology for military operations, rural emergency rooms, and emergency response teams, and is on track for a 510(k) submission.
  • In April 2024, Babson Diagnostics developed a unique hand-warming technology for blood testing, specifically designed for high-quality blood samples from fingertips. The technology, developed in collaboration with biomedical engineering experts, is a step towards addressing the lack of off-the-shelf solutions for blood collection from fingertips. The hand-warming method is a common method used to aid blood collection, but Babson's innovative approach addresses the unique needs of its customers.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global blood warmer devices market report delivers a detailed analysis with 70 key tables, more than 65 visually impactful figures and 159 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Technology
  • 2.5. Snippet by End-User
  • 2.6. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Increasing Prevalence of Hypothermia
      • 3.1.1.2. Advancements In Portable and Battery-Operated Blood Warmer Technologies
    • 3.1.2. Restraints
      • 3.1.2.1. High Cost of Advanced Blood Warmer Devices
      • 3.1.2.2. Stringent Regulatory Approvals and Compliance Requirements
    • 3.1.3. Opportunity
      • 3.1.3.1. Integration of IoT And AI-Based Monitoring Systems for Precise Temperature Control
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with the largest-selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Portable Blood Warmers*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Non-Portable Blood Warmers

6. By Technology

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 6.1.2. Market Attractiveness Index, By Technology
  • 6.2. Dry Heat Plate Warmers*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Water Bath Warmers
  • 6.4. Infrared Warmers

7. By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.1.2. Market Attractiveness Index, By End-User
  • 7.2. Hospitals & Clinics*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Ambulatory Surgical Centers
  • 7.4. Emergency Medical Services

8. Regional Market Analysis and Growth Opportunities

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.6.1. U.S.
      • 8.2.6.2. Canada
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.6.1. Germany
      • 8.3.6.2. U.K.
      • 8.3.6.3. France
      • 8.3.6.4. Spain
      • 8.3.6.5. Italy
      • 8.3.6.6. Rest of Europe
  • 8.4. Latin America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.6.1. Mexico
      • 8.4.6.2. Brazil
      • 8.4.6.3. Argentina
      • 8.4.6.4. Rest of Latin America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.6.1. China
      • 8.5.6.2. India
      • 8.5.6.3. Japan
      • 8.5.6.4. South Korea
      • 8.5.6.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape and Market Positioning

  • 9.1. Competitive Overview and Key Market Players
  • 9.2. Market Share Analysis and Positioning Matrix
  • 9.3. Strategic Partnerships, Mergers & Acquisitions
  • 9.4. Key Developments in Product Portfolios and Innovations
  • 9.5. Company Benchmarking

10. Company Profiles

  • 10.1. 3M*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio
      • 10.1.2.1. Product Description
      • 10.1.2.2. Product Key Performance Indicators (KPIs)
      • 10.1.2.3. Historic and Forecasted Product Sales
      • 10.1.2.4. Product Sales Volume
    • 10.1.3. Financial Overview
      • 10.1.3.1. Company Revenue
      • 10.1.3.2. Geographical Revenue Shares
      • 10.1.3.3. Revenue Forecasts
    • 10.1.4. Key Developments
      • 10.1.4.1. Mergers & Acquisitions
      • 10.1.4.2. Key Product Development Activities
      • 10.1.4.3. Regulatory Approvals, etc.
    • 10.1.5. SWOT Analysis
  • 10.2. Stryker Corporation
  • 10.3. ICU Medical
  • 10.4. Baxter International Inc
  • 10.5. GE Healthcare
  • 10.6. Belmont Medical Technologies
  • 10.7. IndexIndes
  • 10.8. Keewell Medical Technology Co., Ltd
  • 10.9. Narang Medical Limited
  • 10.10. Biegler GmbH

LIST NOT EXHAUSTIVE

11. Assumptions and Research Methodology

  • 11.1. Data Collection Methods
  • 11.2. Data Triangulation
  • 11.3. Forecasting Techniques
  • 11.4. Data Verification and Validation

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us